Literature DB >> 6689996

Transglottic carcinoma.

B Mittal, J E Marks, J H Ogura.   

Abstract

The cases of 152 patients with transglottic carcinoma were reviewed. There were 31% T2, 39% T3, and 30% T4 lesions. Twenty-six percent of patients had neck node metastases at initial presentation, and 19% with no neck dissection or radical irradiation to the neck subsequently developed neck metastases. Patients treated with voice conservation surgery +/- neck dissection +/- radiation (VCS +/- ND +/- R) had small transglottic carcinomas, whereas total laryngectomy +/- neck dissection +/- radiation (TL +/- ND +/- R) was used for patients with larger lesions. The reason for radiation alone (RA) was the patient's poor general condition or refusal of surgery. The total failure rate (primary, neck, and distant metastases) was 39%. Patients treated with TL +/- ND +/- R had fewer primary and stomal failures (12%) than those treated by VCS +/- ND +/- R (23%) and RA (33%), but ultimate failure after salvage treatment was the same (12%-13%). Sixty percent of patients treated with VCS and 67% with RA had their voices preserved. The major complication rate (overall, 16%) was highest in the group treated with VCS +/- ND +/- R. Five-year observed and adjusted survival for the entire group was 47% and 55%, respectively. The lower survival in the RA group was attributable to a high death rate from intercurrent disease. The incidence of second tumors was 14%. Unfavorable prognostic factors were older age, pretreatment tracheostomy, advanced stage and the presence of tumor in surgical specimen, and lymph nodes.

Entities:  

Mesh:

Year:  1984        PMID: 6689996     DOI: 10.1002/1097-0142(19840101)53:1<151::aid-cncr2820530127>3.0.co;2-x

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  10 in total

1.  Treatment and predictive factors in patients with recurrent laryngeal carcinoma: A retrospective study.

Authors:  Peijing Li; Weihan Hu; Yuan Zhu; Jianjiang Liu
Journal:  Oncol Lett       Date:  2015-08-25       Impact factor: 2.967

2.  The periepiglottic space: topographic relations and histological organisation.

Authors:  M M Reidenbach
Journal:  J Anat       Date:  1996-02       Impact factor: 2.610

3.  Borders and topographic relationships of the paraglottic space.

Authors:  M M Reidenbach
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

4.  Pre-operative tracheostomy does not impact on stomal recurrence and overall survival in patients undergoing primary laryngectomy.

Authors:  Thomas F Pezier; Iain J Nixon; Anil Joshi; Leo Pang; Teresa Guerrero-Urbano; Richard Oakley; Jean-Pierre Jeannon; Ricard Simo
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-10-09       Impact factor: 2.503

5.  Glottic Cancer of the Free Margin and Ventricular Surface of Vocal Cord.

Authors:  Gábor Répassy; Jenô Czigner; Ottó Ribári
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

Review 6.  Advanced larynx cancer.

Authors:  Scott E Strome; Eric C Weinman
Journal:  Curr Treat Options Oncol       Date:  2002-02

7.  A study of incidence and pattern of nodal metastases in patients of otorhinolaryngological malignancies.

Authors:  R Srivastava; N Bhatia; M Srivastava
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  1998-07

8.  Normal topography of the conus elasticus. Anatomical bases for the spread of laryngeal cancer.

Authors:  M M Reidenbach
Journal:  Surg Radiol Anat       Date:  1995       Impact factor: 1.246

9.  Treatment of Advanced Carcinoma of the Larynx and Hypopharynx with Laser Followed by External Radiotherapy.

Authors:  Lalee Varghese; John Mathew; Subhashini John; Anand Job
Journal:  Iran J Otorhinolaryngol       Date:  2017-09

10.  Induction chemotherapy in locally advanced pharyngolaryngeal cancers with stridor: is it feasible and safe?

Authors:  Vijay Maruti Patil; Vanita Noronha; Amit Joshi; Vamshi Muddu; Bhavesh Poladia; Bharat Chauhan; Kumar Prabhash; Devendra Arvind Chaukar; Pankaj Chatturvedi; Gouri Pantvaidya; Shashikant Juvekar; Anil D'cruz
Journal:  Chemother Res Pract       Date:  2012-08-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.